Stocks
AnaptysBio (ANAB) Debt/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | 9.46 | 4.01 | 2.39 | 0.17 | -5.91 | -0.31 | ||
| Changes by years, y/y, % | -53% | -58% | -40% | -93% | -3 547% | |||
AnaptysBio. Debt/EBITDA
AnaptysBio. Debt/EBITDA, changes, %
AnaptysBio (ANAB) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| Debt/EBITDA | 3.98 | 4.25 | 4.20 | -21.3 | -0.31 | -0.31 | ||
| Changes by years, y/y, % | +51% | +2 076% | +75% | -737% | -108% | |||
| Changes by quarters, q/q, % | +19% | +7% | -1% | -608% | -99% | |||
